Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOFOS SPILDEVANDSCENTER AVEDØRE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.1% 0.5% 0.7% 1.7% 1.2% 0.5% 22.0% 22.0%   Credit score (0-100)   86 99 95 73 81 99 4 4   Credit rating   A AA AA A A AAA B B   Credit limit (mDKK)   51.1 122.9 117.9 1.7 32.3 124.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   120 132 121 130 123 150 150 150   Gross profit   3.3 7.1 10.0 4.8 -17.6 25.2 0.0 0.0   EBITDA   -0.5 3.0 6.0 0.6 -22.8 19.5 0.0 0.0   EBIT   -0.5 3.0 6.0 0.6 -22.8 19.5 0.0 0.0   Pre-tax profit (PTP)   1.8 6.8 7.8 -19.7 -11.9 26.4 0.0 0.0   Net earnings   1.8 6.8 7.8 -19.7 -11.9 26.4 0.0 0.0   Pre-tax profit without non-rec. items   1.8 6.8 7.8 -19.7 -11.9 26.4 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,041 1,021 1,054 1,091 1,074 1,084 0.0 0.0   Shareholders equity total   1,230 1,236 1,244 1,225 1,213 1,239 0.0 0.0   Interest-bearing liabilities   0.4 0.2 37.1 64.3 73.0 18.5 0.0 0.0   Balance sheet total (assets)   1,271 1,268 1,297 1,302 1,296 1,270 0.0 0.0   Net Debt   -193 -201 -162 -101 -106 -107 0.0 0.0     See the entire balance sheet 1.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   120 132 121 130 123 150 150 150   Net sales growth   -9.0% 10.0% -8.3% 6.9% -5.2% 22.3% 0.0% 0.0%   Gross profit   3.3 7.1 10.0 4.8 -17.6 25.2 0.0 0.0   Gross profit growth   -70.0% 113.1% 41.6% -52.5% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,271 1,268 1,297 1,302 1,296 1,270 0 0   Balance sheet change%   0.4% -0.3% 2.3% 0.4% -0.4% -2.0% -100.0% 0.0%   Added value   -0.5 3.0 6.0 0.6 -22.8 19.5 0.0 0.0   Added value %   -0.5% 2.3% 4.9% 0.5% -18.5% 13.0% 0.0% 0.0%   Investments   -38 -20 34 36 -17 10 -1,084 0   Net sales trend   -1.0 1.0 -1.0 1.0 -1.0 1.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   -0.5% 2.3% 4.9% 0.5% -18.5% 13.0% 0.0% 0.0%   EBIT %   -0.5% 2.3% 4.9% 0.5% -18.5% 13.0% 0.0% 0.0%   EBIT to gross profit (%)   -16.4% 42.7% 59.7% 13.1% 129.6% 77.4% 0.0% 0.0%   Net Earnings %   1.5% 5.1% 6.4% -15.2% -9.7% 17.6% 0.0% 0.0%   Profit before depreciation and extraordinary items %   1.5% 5.1% 6.4% -15.2% -9.7% 17.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   1.5% 5.1% 6.4% -15.2% -9.7% 17.6% 0.0% 0.0%   ROA %   0.2% 0.6% 0.7% 0.3% -0.9% 2.3% 0.0% 0.0%   ROI %   0.2% 0.6% 0.7% 0.3% -0.9% 2.3% 0.0% 0.0%   ROE %   0.1% 0.6% 0.6% -1.6% -1.0% 2.2% 0.0% 0.0%   1.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   96.7% 97.5% 96.0% 94.1% 93.5% 97.6% 0.0% 0.0%   Relative indebtedness %   29.0% 18.3% 37.2% 53.1% 61.0% 14.6% 0.0% 0.0%   Relative net indebtedness %   -131.6% -133.8% -127.0% -74.0% -84.1% -69.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   35,413.0% -6,655.1% -2,706.6% -16,185.7% 463.0% -549.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 3.0% 5.2% 6.0% 1.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   15.0% 180.6% 7.7% 46.0% 0.0% 7.6% 0.0% 0.0%   1.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   10.6 18.6 6.5 3.2 3.0 8.4 0.0 0.0   Current Ratio   10.6 18.6 6.5 3.2 3.0 8.4 0.0 0.0   Cash and cash equivalent   193.4 201.6 199.4 165.1 178.6 125.9 0.0 0.0   1.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   106.3 48.1 50.6 47.8 48.7 59.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   191.6% 186.4% 199.6% 162.5% 180.6% 123.4% 0.0% 0.0%   Net working capital   71.6 57.5 27.6 -12.2 -19.7 57.3 0.0 0.0   Net working capital %   59.4% 43.4% 22.7% -9.4% -16.0% 38.1% 0.0% 0.0%   1.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0